Journal of Clinical Endocrinology & Metabolism, Vol 80, 2227-2232, Copyright © 1995 by Endocrine Society

ARTICLES

Calcium-regulating hormones across the menstrual cycle: evidence of a secondary hyperparathyroidism in women with PMS

S Thys-Jacobs and MJ Alvir
Mount Sinai Medical Center, New York, New York, USA.

Calcium metabolism across one menstrual cycle was studied in 12 healthy, premenopausal women. Seven women had documented premenstrual syndrome (PMS), and five were asymptomatic controls. Fasting blood samples were drawn at six points throughout the ovulatory cycle. In both the asymptomatic and the PMS groups, total and ionized calcium declined significantly at midcycle with the increase of estradiol. In the PMS group only, peak midcycle intact PTH was significantly elevated by approximately 30% compared with early follicular levels (49 +/- 25 vs. 37 +/- 22 ng/L, t = 3.79, P = 0.009). In the asymptomatic group, iPTH did not vary during the menstrual cycle. Midcycle iPTH was significantly higher in the PMS group compared with that of the control group (49 +/- 25 vs. 26 +/- 7 ng/L, Wilcoxon Z = 2.28, P = 0.02). Multivariate analysis showed that total and ionized calcium both varied significantly across the menstrual cycle. Significant differences between groups were found for total calcium, 25OHD, and 1,25-(OH)2D. One woman with PMS was treated with oral elemental calcium and cholecalciferol daily for 3 months, with amelioration of her symptoms. Midcycle iPTH and 1,25-(OH)2D declined after repletion of 25OHD. In conclusion, we found that concentrations of total and ionized calcium significantly fluctuate during the menstrual cycle both in symptomatic and in asymptomatic women. We also found that concentrations of iPTH, 25OHD, and 1,25-(OH)2D differed between groups during specific phases of the menstrual cycle. Our data suggest that women with PMS have midcycle elevations of iPTH with a transient, secondary hyperparathyroidism.

This article has been cited by other articles:

				E. R. Bertone-Johnson, S. E. Hankinson, S. R. Johnson, and J. E. Manson Cigarette Smoking and the Development of Premenstrual Syndrome Am. J. Epidemiol., October 15, 2008; 168(8): 938 - 945. [Abstract] [Full Text] [PDF]

				S. Thys-Jacobs, D. McMahon, and J. P. Bilezikian Cyclical Changes in Calcium Metabolism across the Menstrual Cycle in Women with Premenstrual Dysphoric Disorder J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 2952 - 2959. [Abstract] [Full Text] [PDF]

				E. R. Bertone-Johnson, S. E. Hankinson, A. Bendich, S. R. Johnson, W. C. Willett, and J. E. Manson Calcium and Vitamin D Intake and Risk of Incident Premenstrual Syndrome Arch Intern Med, June 13, 2005; 165(11): 1246 - 1252. [Abstract] [Full Text] [PDF]

				M. Carr Treatments for premenstrual dysphoric disorder Fam. Pract., December 1, 2001; 18(6): 644 - 646. [Full Text] [PDF]

				U. Halbreich and L. S. Kahn Are Women With Premenstrual Dysphoric Disorder Prone to Osteoporosis? Psychosom Med, May 1, 2001; 63(3): 361 - 364. [Abstract] [Full Text] [PDF]

				S. Thys-Jacobs Micronutrients and the Premenstrual Syndrome: The Case for Calcium J. Am. Coll. Nutr., April 1, 2000; 19(2): 220 - 227. [Abstract] [Full Text] [PDF]

				I. Gorai, Y. Taguchi, O. Chaki, R. K. M. Nakayama, B. C. Yang, S. Yokota, and H. Minaguchi Serum Soluble Interleukin-6 Receptor and Biochemical Markers of Bone Metabolism Show Significant Variations During the Menstrual Cycle J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 326 - 332. [Abstract] [Full Text]